Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 230

Similar articles for PubMed (Select 9294377)

1.

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.

Gillberg C, Melander H, von Knorring AL, Janols LO, Thernlund G, Hägglöf B, Eidevall-Wallin L, Gustafsson P, Kopp S.

Arch Gen Psychiatry. 1997 Sep;54(9):857-64.

PMID:
9294377
4.
6.
7.

A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.

Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA; Modafinil ADHD Study Group.

J Clin Psychiatry. 2006 May;67(5):727-35.

PMID:
16841622
8.

Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study.

Spencer TJ, Landgraf JM, Adler LA, Weisler RH, Anderson CS, Youcha SH.

J Clin Psychiatry. 2008 Nov;69(11):1766-75. Epub 2008 Nov 4.

PMID:
19026251
10.

Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.

Konstenius M, Jayaram-Lindström N, Beck O, Franck J.

Drug Alcohol Depend. 2010 Apr 1;108(1-2):130-3. doi: 10.1016/j.drugalcdep.2009.11.006. Epub 2009 Dec 16.

PMID:
20015599
11.
12.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
13.
14.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
15.

A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.

Kahbazi M, Ghoreishi A, Rahiminejad F, Mohammadi MR, Kamalipour A, Akhondzadeh S.

Psychiatry Res. 2009 Aug 15;168(3):234-7. doi: 10.1016/j.psychres.2008.06.024. Epub 2009 May 12.

PMID:
19439364
17.
18.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
19.

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.

Greenhill LL, Findling RL, Swanson JM; ADHD Study Group.

Pediatrics. 2002 Mar;109(3):E39.

PMID:
11875167
20.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk